Theranexus Company Profile

12:27 EDT 23rd March 2017 | BioPortfolio

News Articles [2 Associated News Articles listed on BioPortfolio]

Theranexus begins enrolment for Phase II trial of THN102 to treat narcolepsy-caused sleepiness

Theranexus has enrolled the first patient for its Phase II clinical study of THN102 to treat excessive daytime sleepiness associated with narcolepsy in adult patients.

Inclusion du premier patient dans le cadre de l’étude clinique de phase II visant à tester THN102 chez des patients atteints de narcolepsie

Thursday, October 27th 2016 at 12:30pm UTC Cet essai vise à démontrer la supériorité d’efficacité de THN102 par rapport au traitement de référence chez le patient narcoleptique LYON, France&#...

Drugs and Medications [0 Results]


PubMed Articles [0 Results]


Clinical Trials [0 Results]


More Information about "Theranexus" on BioPortfolio

We have published hundreds of Theranexus news stories on BioPortfolio along with dozens of Theranexus Clinical Trials and PubMed Articles about Theranexus for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Theranexus Companies in our database. You can also find out about relevant Theranexus Drugs and Medications on this site too.

Quick Search

Corporate Database Quicklinks

Searches Linking to this Company Record